7A9-24444-20987
5 vaccinations
5 coded responses
57 check-ins
5 free-text entries
4 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 376 / TN
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-01
- 2021-02-08
- 2021-02-15
-
2021-02-16
Dose 2 — Pfizer-BioNTech
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-03-16
Survey response — day 28, dose 2MedDRA: Ocular discomfort, Ocular hyperaemia — Feeling: GoodFree text: Ruptured blood vessels in right eye and some eye discomfortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-30
-
2021-05-18
Survey response — 3 months, dose 2MedDRA: Office visit, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Rash on chest and shoulders · Healthcare visit (other): Dermatologist officeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-17
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-12
-
2021-10-19
Survey response — day 14, dose 3MedDRA: Arthralgia, Back pain, Dyspnoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper back and shoulder pain. Shortness of breath.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — day 14, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-21
Call successfulNot applicable - Accidental Reporting
-
2021-10-21
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-16
- 2022-01-04
- 2022-04-05
-
2022-04-07
Dose 4 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-07-07
-
2022-09-28
Dose 5 — Pfizer-BioNTech
-
2022-09-29
Health check-in — days 1–6 daily, dose 5Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-12
-
2022-10-19
Survey response — day 21, dose 5MedDRA: Heart rate increased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Tachycardia - rapid and sustained high heart rate.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Report sent to call center — day 21, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-10-20
-
2022-10-20
Callback requested for02:30PM ET
-
2022-10-20
Call successfulCompleted over the phone
- 2022-10-26
- 2022-11-02
- 2022-11-09
-
2022-12-28
Survey response — 3 months, dose 5MedDRA: Tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Because of tachycardia incident previously reported to you two weeks after last Covid vaccination, cardiologist prescribed beta blocker and blood pressure prescriptions for me. No new tachycardia incidents but prescribed medications now necessary.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-28
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-29
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-04-07 | Pfizer-BioNTech | No |
| 5 | 2022-09-28 | Pfizer-BioNTech | No |
Call center
4 call center cases
3 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
Free text
Release 5 — day 28, dose 2
Symptoms: Ruptured blood vessels in right eye and some eye discomfort
Release 8 — 3 months, dose 2
Release 10 — day 14, dose 3
Symptoms: Upper back and shoulder pain. Shortness of breath.
Release 12 — day 21, dose 5
Symptoms: Tachycardia - rapid and sustained high heart rate.
Release 12 — 3 months, dose 5
Symptoms: Because of tachycardia incident previously reported to you two weeks after last Covid vaccination, cardiologist prescribed beta blocker and blood pressure prescriptions for me. No new tachycardia incidents but prescribed medications now necessary. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Ocular discomfort | ✓ | ✓ | ✓ |
| SD | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release